• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病中肾小球基因的长期表达。

Long-term expression of glomerular genes in diabetic nephropathy.

机构信息

Department of Nephrology, University hospital Regensburg, Regensburg, Germany.

Kompetenzzentrum Fluoreszente Bioanalytik (KFB), Regensburg, Germany.

出版信息

Nephrol Dial Transplant. 2018 Sep 1;33(9):1533-1544. doi: 10.1093/ndt/gfx359.

DOI:10.1093/ndt/gfx359
PMID:29340699
Abstract

BACKGROUND

Although diabetic nephropathy (DN) is the most common cause for end-stage renal disease in western societies, its pathogenesis still remains largely unclear. A different gene pattern of diabetic and healthy kidney cells is one of the probable explanations. Numerous signalling pathways have emerged as important pathophysiological mechanisms for diabetes-induced renal injury.

METHODS

Glomerular cells, as podocytes or mesangial cells, are predominantly involved in the development of diabetic renal lesions. While many gene assays concerning DN are performed with whole kidney or renal cortex tissue, we isolated glomeruli from black and tan, brachyuric (BTBR) obese/obese (ob/ob) and wildtype mice at four different timepoints (4, 8, 16 and 24 weeks) and performed an mRNA microarray to identify differentially expressed genes (DEGs). In contrast to many other diabetic mouse models, these homozygous ob/ob leptin-deficient mice develop not only a severe type 2 diabetes, but also diabetic kidney injury with all the clinical and especially histologic features defining human DN. By functional enrichment analysis we were able to investigate biological processes and pathways enriched by the DEGs at different disease stages. Altered expression of nine randomly selected genes was confirmed by quantitative polymerase chain reaction from glomerular RNA.

RESULTS

Ob/ob type 2 diabetic mice showed up- and downregulation of genes primarily involved in metabolic processes and pathways, including glucose, lipid, fatty acid, retinol and amino acid metabolism. Members of the CYP4A and ApoB family were found among the top abundant genes. But more interestingly, altered gene loci showed enrichment for processes and pathways linked to angioneogenesis, complement cascades, semaphorin pathways, oxidation and reduction processes and renin secretion.

CONCLUSION

The gene profile of BTBR ob/ob type 2 diabetic mice we conducted in this study can help to identify new key players in molecular pathogenesis of diabetic kidney injury.

摘要

背景

虽然糖尿病肾病(DN)是西方社会终末期肾病的最常见原因,但其发病机制仍很大程度上不清楚。糖尿病和健康肾脏细胞的不同基因模式是其中一个可能的解释。许多信号通路已成为糖尿病引起的肾损伤的重要病理生理机制。

方法

肾小球细胞,如足细胞或系膜细胞,主要参与糖尿病肾脏病变的发展。虽然许多关于 DN 的基因检测都是在整个肾脏或肾皮质组织中进行的,但我们从黑棕杂色、短胖(BTBR)肥胖/肥胖(ob/ob)和野生型小鼠的肾小球中分离出来,并在四个不同时间点(4、8、16 和 24 周)进行了 mRNA 微阵列分析,以鉴定差异表达基因(DEGs)。与许多其他糖尿病小鼠模型不同,这些纯合子 ob/ob 瘦素缺乏小鼠不仅会发展出严重的 2 型糖尿病,而且还会出现糖尿病肾病损伤,具有所有定义人类 DN 的临床和特别是组织学特征。通过功能富集分析,我们能够研究不同疾病阶段 DEGs 富集的生物学过程和途径。通过定量聚合酶链反应从肾小球 RNA 中验证了随机选择的 9 个基因的表达变化。

结果

ob/ob 型 2 型糖尿病小鼠的基因表达上调和下调主要涉及代谢过程和途径,包括葡萄糖、脂质、脂肪酸、视黄醇和氨基酸代谢。CYP4A 和 ApoB 家族的成员被发现是最丰富的基因之一。但更有趣的是,改变的基因座富集了与血管生成、补体级联、神经鞘氨醇途径、氧化还原过程和肾素分泌相关的过程和途径。

结论

我们在这项研究中对 BTBR ob/ob 型 2 型糖尿病小鼠进行的基因谱分析有助于鉴定糖尿病肾病损伤分子发病机制中的新关键因素。

相似文献

1
Long-term expression of glomerular genes in diabetic nephropathy.糖尿病肾病中肾小球基因的长期表达。
Nephrol Dial Transplant. 2018 Sep 1;33(9):1533-1544. doi: 10.1093/ndt/gfx359.
2
Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice.肌肽可减轻 BTBR ob/ob 小鼠 2 型糖尿病和糖尿病肾病的发展。
Sci Rep. 2017 Mar 10;7:44492. doi: 10.1038/srep44492.
3
Glomerular expression pattern of long non-coding RNAs in the type 2 diabetes mellitus BTBR mouse model.2 型糖尿病 BTBR 小鼠模型中长非编码 RNA 的肾小球表达模式。
Sci Rep. 2019 Jul 5;9(1):9765. doi: 10.1038/s41598-019-46180-1.
4
Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy.药理学 PAR-1 抑制可降低血糖水平,但不能改善实验性 2 型糖尿病肾病的肾功能。
FASEB J. 2019 Oct;33(10):10966-10972. doi: 10.1096/fj.201900516R. Epub 2019 Jul 9.
5
Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease.单细胞 RNA 谱分析肾小球细胞显示实验性糖尿病肾病中的动态变化。
J Am Soc Nephrol. 2019 Apr;30(4):533-545. doi: 10.1681/ASN.2018090896. Epub 2019 Mar 7.
6
Single-cell transcriptomics reveals a mechanosensitive injury signaling pathway in early diabetic nephropathy.单细胞转录组学揭示了早期糖尿病肾病中的机械敏感性损伤信号通路。
Genome Med. 2023 Jan 10;15(1):2. doi: 10.1186/s13073-022-01145-4.
7
Grem2 mediates podocyte apoptosis in high glucose milieu.Grem2 介导高糖环境中的足细胞凋亡。
Biochimie. 2019 May;160:113-121. doi: 10.1016/j.biochi.2019.02.015. Epub 2019 Mar 1.
8
The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.钠-葡萄糖协同转运蛋白 2 抑制剂恩格列净可改善伴有和不伴有高血压的 BTBR ob/ob 2 型糖尿病小鼠早期糖尿病肾病的特征。
Am J Physiol Renal Physiol. 2014 Aug 1;307(3):F317-25. doi: 10.1152/ajprenal.00145.2014. Epub 2014 Jun 18.
9
BTBR Ob/Ob mutant mice model progressive diabetic nephropathy.BTBR Ob/Ob 突变型小鼠模型表现出进行性糖尿病肾病。
J Am Soc Nephrol. 2010 Sep;21(9):1533-42. doi: 10.1681/ASN.2009121290. Epub 2010 Jul 15.
10
Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.时间表达谱和分布模式表明结缔组织生长因子(CTGF/CCN-2)在小鼠糖尿病肾病中发挥作用。
Am J Physiol Renal Physiol. 2006 Jun;290(6):F1344-54. doi: 10.1152/ajprenal.00174.2005. Epub 2005 Dec 27.

引用本文的文献

1
Circulating Protein and Metabolite Correlates of Histologically Confirmed Diabetic Kidney Disease.经组织学确诊的糖尿病肾病的循环蛋白和代谢物关联
Kidney Med. 2024 Oct 16;6(12):100920. doi: 10.1016/j.xkme.2024.100920. eCollection 2024 Dec.
2
Admixture Mapping of Chronic Kidney Disease and Risk Factors in Hispanic/Latino Individuals From Central America Country of Origin.中美洲原籍的西班牙裔/拉丁裔个体的慢性肾脏病及其危险因素的混合映射。
Circ Genom Precis Med. 2024 Aug;17(4):e004314. doi: 10.1161/CIRCGEN.123.004314. Epub 2024 Jul 1.
3
Retinol intake is associated with the risk of chronic kidney disease in individuals with type 2 diabetes mellitus: results from NHANES.
视黄醇摄入与 2 型糖尿病患者慢性肾脏病风险相关:来自 NHANES 的结果。
Sci Rep. 2023 Jul 18;13(1):11567. doi: 10.1038/s41598-023-38582-z.
4
What the BTBR/J mouse has taught us about diabetes and diabetic complications.BTBR/J小鼠让我们了解到的关于糖尿病及糖尿病并发症的知识。
iScience. 2023 Jun 7;26(7):107036. doi: 10.1016/j.isci.2023.107036. eCollection 2023 Jul 21.
5
The Interplay of NEAT1 and miR-339-5p Influences on Mesangial Gene Expression and Function in Various Diabetic-Associated Injury Models.NEAT1与miR-339-5p的相互作用对多种糖尿病相关损伤模型中系膜基因表达和功能的影响
Noncoding RNA. 2022 Jul 13;8(4):52. doi: 10.3390/ncrna8040052.
6
Microbiota and Transcriptomic Effects of an Essential Oil Blend and Its Delivery Route Compared to an Antibiotic Growth Promoter in Broiler Chickens.与抗生素生长促进剂相比,混合精油及其给药途径对肉鸡微生物群和转录组的影响
Microorganisms. 2022 Apr 21;10(5):861. doi: 10.3390/microorganisms10050861.
7
The Complement Pathway: New Insights into Immunometabolic Signaling in Diabetic Kidney Disease.补体途径:糖尿病肾病中免疫代谢信号的新见解。
Antioxid Redox Signal. 2022 Oct;37(10-12):781-801. doi: 10.1089/ars.2021.0125. Epub 2022 Feb 7.
8
Extracellular vesicle-derived AEBP1 mRNA as a novel candidate biomarker for diabetic kidney disease.细胞外囊泡衍生的 AEBP1 mRNA 作为糖尿病肾病的一种新型候选生物标志物。
J Transl Med. 2021 Jul 31;19(1):326. doi: 10.1186/s12967-021-03000-3.
9
Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects.eNOS基因敲除小鼠中糖尿病肾病和神经病变的基因表达谱:病理预测指标及RAS阻断效应
FASEB J. 2021 May;35(5):e21467. doi: 10.1096/fj.202002387R.
10
Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes.SOCS1 模拟肽对 2 型糖尿病 BTBR ob/ob 小鼠模型的抗炎、抗氧化和肾保护作用。
BMJ Open Diabetes Res Care. 2020 Sep;8(1). doi: 10.1136/bmjdrc-2020-001242.